Selank for Sale — Lab-Tested Selank (TP-7) at 99.2% HPLC Purity

Selank 10mg research peptide vial from Amino Fuel Labs

Selank is a tuftsin-derived heptapeptide supplied by Amino Fuel Labs for laboratory research in anxiolytic and stress research, gabaergic system modulation, cognitive performance studies. This listing covers a single lyophilized powder configuration, each released against a batch-specific third-party Certificate of Analysis reporting 99.4% purity by reversed-phase HPLC. Vials ship from our US facility with lot documentation matching the exact batch you receive. Research use only.

$55.00 — In stock, ships same business day

Selank Research Overview

Selank is a 7-amino-acid synthetic peptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed by the Russian Institute of Molecular Genetics as a stable analog of the endogenous immunopeptide tuftsin.

Available Selank Research Strengths

Purity and Laboratory Testing

Lot AFL-SELANK-2026-001 (tested 2026-03-29) of Selank was assayed by an independent laboratory using reversed-phase HPLC for purity and mass spectrometry for identity confirmation, returning 99.4% purity. The Certificate of Analysis shipped in the box matches the lot number printed on the vial.

Technical Product Information

Molecular formula C₃₃H₅₇N₁₁O₉, molecular weight 751.87 g/mol, sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Selank modulates GABAergic transmission, upregulates BDNF expression and influences serotonin/dopamine turnover. Unlike benzodiazepines it does not directly bind GABA-A receptors, which is why preclinical work shows anxiolytic activity without sedation, tolerance or withdrawal. Selank is supplied as lyophilized powder and is classified in our catalog under tuftsin-derived heptapeptide for tuftsin-derived heptapeptide work. Recorded research categories for this compound include anxiolytic and stress research, gabaergic system modulation, cognitive performance studies, immunomodulation and tuftsin research. Handling notes: store at -20°c (freezer), protect the vial from light, and avoid repeated freeze–thaw cycles once reconstituted. Amino Fuel Labs publishes no dosing protocol for Selank: the compound is distributed for in-vitro and preclinical laboratory research only and is not intended for human or veterinary use.

Certificate of Analysis

View the Selank Certificate of Analysis for the current lot, including HPLC purity and mass-spectrometry identity data.

Frequently Asked Questions

How is Selank different from benzodiazepines in research?

Selank shows anxiolytic activity in preclinical models without binding GABA-A receptors directly. The result is no observed sedation, no tolerance development and no withdrawal — the main limitations of benzodiazepine research.

Can Selank be stacked with Semax?

In research literature the two are often combined because their mechanisms are complementary: Selank for anxiolytic/GABAergic effects and Semax for nootropic/dopaminergic effects.

Do you provide a COA?

Yes. Every batch ships with HPLC ≥99.4%, mass-spec confirmation and endotoxin testing on the COA.

What is Selank studied for?

Selank appears in laboratory research covering anxiety research, cognitive enhancement, immune modulation. All references describe in-vitro and preclinical study models only.

Does Selank include a Certificate of Analysis?

Yes. Each Selank lot ships with a batch-specific third-party Certificate of Analysis reporting 99.4% purity by reversed-phase HPLC alongside mass-spectrometry identity confirmation.

What form does Selank arrive in?

Selank is supplied as lyophilized powder in a sealed vial, packed with the lot documentation for the exact batch shipped.

Related Research Products

Research Use Only

Selank is supplied strictly for laboratory research use. It is not a drug, food or cosmetic and is not intended for human or veterinary use, consumption, diagnosis, treatment or prevention of any condition. Amino Fuel Labs publishes no human dosing or administration guidance.

Browse all research peptides for sale · View third-party lab reports · Read the research peptide FAQ